Long-term activity index after renal failure in a cohort of 32 patients with lupus nephritis

Clinical and Experimental Rheumatology

Volumn 32, Issue 3, 2014, Pages 301-307

  González Pulido, Cristina ^a   Croca, Sara ^b   Abrol, Esha ^c   Isenberg, David A ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

BILAG index; Disease activity; Lupus nephritis; Outcome; Renal failure

Indexed keywords

AZATHIOPRINE; DOUBLE STRANDED DNA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ARTICLE; BRITISH ISLES LUPUS ASSESSMENT GROUP ACTIVITY INDEX; CADAVER DONOR; CAUSE OF DEATH; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MUCOSAL DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REFERENCE VALUE; RENAL GRAFT DYSFUNCTION; RETROSPECTIVE STUDY; SEROLOGICAL INVOLVEMENT INDEX; SKIN DISEASE; TIME TO TREATMENT; TREATMENT DURATION; TREATMENT FAILURE;

ADULT; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84901836672     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. LIANG C, HUANG C, WANG I et al.: Impact of renal survival on the course and outcome of systemic lupus erythematosus patients treated with chronic peritoneal dialysis. Ther Apher Dial 2010; 14: 35-42.
2. NOSSENT H, SWAAK T, BERDEN J: Systemic lupus erythematosus: analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Dutch Working Party on SLE. Am J Med 1990; 89: 169-74.
3. WARD M: Changes in the incidence of end stage renal disease due to lupus nephritis, 1982-1995. Arch Intern Med 2000; 160: 3136-40.
4. CHEIGH J, KIM H, STENZEL K et al.: Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity. Am J Kidney Dis 1990; 16: 189-95.
5. ADLER M, CHAMBERS S, EDWARDS C, NEILD G, ISENBERG DA: An assessment of renal failure in an SLE cohort with special reference to ethnicity over a 25-year period. Rheumatology 2006; 45: 1144-47.
6. COPLON N, SIEGEL R, FRIES J: Haemodialysis on end-stage lupus nephritis. Trans Am Soc Artif Intern Organs 1973; 19: 302-04.
7. FRIES JF, POWERS R, KEMPSON RL: Late-stage lupus nephropathy. J Rheumatol 1974; 1: 166-75.
8. MATTOS P, SANTIAGO MB: Disease activity in systemic lupus erythematosus patients with end-stage renal disease: systematic review of the literature. Clin Rheumatol 2012; 31: 897-905.
9. SYMMONS DP, COPPOCK JS, BACON PA et al.: Devolopment and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Q J Med 1988; 69: 927-37.
10. STOLL T, STUCKI G, MALIK J, PIKE S, ISENBERG DA: Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus. Ann Rheum Dis 1996; 55: 756-60.
11. GORDON C, SUTCLIFFE N, SKAN J, STOLL T, ISENBERG DA: Definition and treatment of lupus flares measured by the BILAG index. Rheumatology (Oxford) 2003; 42: 1372-79.
12. CROCA SC, RODRIGUES T, ISENBERG DA: Assessment of a lupus nephritis cohort over a 30-year period. Rheumatology (Oxford) 2011; 50: 1424-30.
13. JARRETT MP, SANTHANAM S, DEL GRECO F: The clinical course of end-stage renal disease in systemic lupus erythematosus. Arch Intern Med 1983; 143: 1353-56.
14. KIMBERLY RP, LOCKSHIN MD, SHERMAN RL, BEARY JF, MOURADIAN J, CHEIGH JS: 'End-stage' lupus nephritis: clinical course to and outcome on dialysis. Experience with 39 patients. Medicine 1981; 60: 277-87.
15. KAUL H, GIRNDT M, SESTER U, SESTER M, KÖ HLER H: Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease. Am J Kidney Dis 2000; 35: 611-16.
16. BURGOS PI, PERKINS EL, PONS-ESTEL GJ et al.: Risk Factors and Impact of Recurrent Lupus Nephritis in Patients With Systemic Lupus Erythematosus undergoing renal transplantation: data from a single US institution. Arthritis Rheum 2009; 60: 2757-66.
17. VILLAVERDE-VERDEJO P, FERNÁ NDEZ-RIVERA C, ALONSO-HERNÁ NDEZ A et al.: Evaluation of renal grafts in patients with lupus nephritis as cause of end-stage renal disease. Transplant Proc 2005; 37: 1426-27.
18. KRANE NK, BURJAK K, ARCHIE M, ÓDONOVAN R: Persistent lupus activity in end stage renal disease. Am J Kidney Dis 1999; 33: 872-79.
19. GOO YS, PARK HC, CHOI HY et al.: The evolution of lupus activity among patients with end-stage renal disease secondary to lupus nephritis. Yonsei Med J 2004; 45: 199-206.
20. LEE PT, FANG HC, CHEN CL, CHIOU YH, CHOU KJ, CHUNG HM: Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patients. Lupus 2003; 12: 827-32.
21. MOON S, PARK H, KWOK S, JU J, KIM H, PARK S: Predictors of end-stage renal disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis. Clin Exp Rheumatol 2013; 31: 31-9.
22. ZEN M, BASSI N, NALOTTO L et al.: Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study. Clin Exp Rheumatol 2012; 30: 856-63.
23. MOSCA M, BOUMPAS D, BRUCE IN et al.: Treat to target in systemic lupus erythematosus: where are we today? Clin Exp Rheumatol 2012; 30 (Suppl. 73): S112-5.
24. LIANG MH, SOCHER SA, LARSON MG, SCHUR PH: Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-18.
25. OKANO K, YUMURA W, NITTA K et al.: Analysis of lupus activity in end-stage renal disease treated by haemodialysis. Intern Med (Tokyo, Japan) 2001; 40: 598-602.
26. KANG SH, CHUNG BH, CHOI SR et al.: Comparison of clinical outcomes by different renal replacement therapy in patients with end-stage renal disease secondary to lupus nephritis. Korean J Intern Med 2011; 26: 60-67.
27. KOBAYASHI M, IITSUKA T, ISHIZU T et al.: Clinicopathological study of dialysis patients with lupus nephritis. Nihon Jinzo Gakkai Shi 1995; 37: 456-61.
28. COPLON NS, DISKIN CJ, PETERSEN J, SWENSON RS: The long-term clinical course of systemic lupus erythematosus in end-stage renal disease. New Engl J Med 1983; 308: 186-90.
29. RODBY RA, KORBET SM, LEWIS EJ: Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis. Am J Med 1987; 83: 613-18.
30. BRUCE IN, HALLETT DC, GLADMAN DD, UROWITZ MB: Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy. J Rheumatol 1999; 26: 1490-84.
31. RIBEIRO FM, LEITE MA, VELARDE GC, FABRIS CL, SANTOS RC, LUGON JR: Activity of systemic lupus erythematosus in end-stage renal disease patients: study in a Brazilian cohort. Am J Nephrol 2005; 25: 596-603.
32. PETRI M, PEREZ-GUTTHANN S, LONGENECKER JC, HOCHBERG M: Morbidity of systemic lupus erythenatosus: role of race and socioeconomic status. Am J Med 1991; 9: 345-53.
33. BARR RG, SELIGER S, APPEL GB et al.: Prognosis in proliferative lupus nephritis: the role of socioenomic status and race/ethnicity. Nephrol Dial Transplant 2003; 18: 2039-46.
34. SIRES RL, ADLER SG, LOUIE JS, COHEN AH: Poor prognosis in end-stage lupus nephritis due to nonautologous vascular access site associated septicemia and lupus flares. Am J Nephrol 1989; 9: 279-84.
35. SIU YP, LEUNG KT, TONG MK, KWAN TH, MOK CC: Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2005; 20: 2797-802.
36. BUNNAPRADIST S, CHUNG P, PENG A et al.: Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database. Transplantation 2006; 82: 612-8.
37. TANG H, CHELAMCHARLA M, BAIRD BC, SHIHAB FS, KOFORD JK, GOLDFARB-RUMYANTZEV AS: Factors affecting kidney-transplant outcome in recipients with lupus nephritis. Clin Transplant 2008; 22: 263-72.
38. OLIVEIRA CS, D'OLIVEIRA I, BACCHIEGA AB et al.: Renal transplation in lupus nephritis: a Brazilian cohort. Lupus 2011; 21: 570-74.
39. BRODER A, KHATTRI S, PATEL R, PUTTERMAN C: Undertreatment of disease activity in systemic lupus erythematosus patients with endstage renal failure is associated with increased all-cause mortality. J Rheumatol 2011; 38: 2382-89.